The generic version of Crestor — rosuvastatin — cost Patrik Swanljung of Anacortes, Wash., about $38 less when he bought it through a website rather than using his health insurance. Consumers are finding that they can sometimes save money on their drug costs by not using their insurance

Quick Read

Thirty years ago this October, Merck & Co. vowed that it would immediately begin distributing the drug free of charge, to any country that requested it, “for as long as needed.” It was the final piece of the puzzle: an effective drug for a tragic and completely preventable disease. And we all lived happily ever after. Only… we didn’t.

Quick Read

Repeated blood draws during a hospital stay can have a negative impact on a patient’s health and contribute to rising health care costs. In a review article published this week in JAMA Internal Medicine, physicians at Johns Hopkins joined an international team that crafted an improvement blueprint to reduce repetitive lab testing for hospitalized patients

Quick Read

A federal judge in Texas invalidated four key patents for the dry-eye treatment Restasis on Monday, dealing a blow to its manufacturer, Allergan, which had sought to protect its patents by transferring them to a Native American tribe

Quick Read

In a deal similar to the one that turned the tide against AIDS, manufacturers and charities will make chemotherapy drugs available in six poor countries at steep discounts

Quick Read

With the country in the throes of an epidemic, communities across the nation are being forced to confront the harrowing, and often fatal, effects of opioid abuse. But solutions — such as creating intervention programs in Ohio, providing access to treatment in Alabama, or investing in prevention initiatives in Missouri — cost money

Quick Read

Faiz Gani, Joseph Sakran and Joseph Canner of the Johns Hopkins University School of Medicine collected numbers representing more than 704,000 people who visited hospitals to treat gunshot wounds between 2006 and 2014

Quick Read

High-quality health data is the backbone of strong public health policies. When government officials and public health professionals understand the factors that influence health, they can make informed decisions about how and where to target public health interventions and resources

Quick Read